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Abstract 
The transport of L-glutamate by lactating rat mammary gland has been examined using both tissue explants and a perfused mammary 
preparation. L-Glutamate uptake by mammary tissue explants was predominantly via a Na+-dependent pathway: Li +, choline + and 
NMDG + could not substitute for Na +. L-Glutamate fflux from preloaded explants was also influenced by the transmembrane 
Na+-gradient. These results are consistent with (Na+-glutamate) cotransport. The Na+-dependent system for L-glutamate transport in 
tissue explants was saturable (K m = 112.5 _+ 19.7 IxM; Vm~ x = 71.3 _+ 10.4 nmol/min per g cells) and selective for anionic amino acids. 
Thus, D- and L-aspartate were high affinity inhibitors of L-glutamate uptake whereas neutral amino acids were relatively ineffective. 
o-Aspartate inhibited L-ghitamate uptake in a competitive fashion. L-Glutamate uptake by the perfused mammary gland was (a) 
Na+-dependent (b) saturable (Km = 18.1 _+ 4.9 p,M; Vma x= 40.3 _ 3.7 nmol/min per g tissue) and (c) selective for anionic amino acids. 
The results suggest that the (Na+-glutamate) cotransporter is situated in the blood-facing aspect of the mammary epithelium. 
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1. Introduction 
L-Glutamate transport has been extensively studied in a 
large variety of cells and tissues. It appears that there are 
several systems which are capable of transporting this 
anionic amino acid across the plasma membranes of mam- 
malian cells. Firstly, a high affinity (K  m 1-290 IxM), 
Na+-dependent mechanism, designated XAC [1] has been 
described. This system plays an important role in terminat- 
ing neurotransmission by removing L-glutamate from the 
synaptic cleft [2,3]. System XA~ also plays a role in the 
transport of L-glutamate in tissues such as the intestine, 
kidney, liver and placenta [3]. It appears that this mecha- 
nism operates by cotransporting two Na + ions with one 
glutamate in exchange for one K ÷ and one OH-  [4,5]. 
System XA~ is characterised by being able to discriminate 
between the optical isomers of glutamate but not those of 
aspartate. Recently, several of the high-affinity Na+-de - 
pendent glutamate transporters have been cloned and their 
primary amino acid sequences determined [6-8]. Secondly, 
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a low affinity (K  m 2-4 mM), Na+-dependent L-glutamate 
transporter has been identified in the intestine [9]. Interest- 
ingly, the low affinity pathway appears to have a substrate 
specificity similar to that of system XA~. Thirdly, a Na +- 
independent system, named x c, is capable of transporting 
L-glutamate and cystine [1,10]. This transport mechanism 
may be important for regulating the levels of intracellular 
glutathione, a glutamate containing peptide, which is in- 
volved in protecting cells from oxidative stress. 
Whilst the transport of L-glutamate has been thoroughly 
studied in kidney, intestine, placenta, liver and neuronal 
tissue other tissues have been overlooked. In this connec- 
tion the transport of L-glutamate, and other anionic amino 
acids, by the lactating mammary gland has not received the 
attention it deserves. The lactating mammary gland has a 
high demand for glutamate in order to satisfy its demand 
for protein synthesis (for a review see [1 l]). Indeed, gluta- 
mate is the most abundant amino acid in milk protein 
accounting for 12% of the total amino acid residues in et 
S1 casein of bovine milk [12]. The mammary gland is able 
to generate a large arteriovenous L-glutamate concentration 
difference suggesting that mammary secretory cells pos- 
sess a system(s) for transporting L-glutamate [ 13-16]. 
In view of the paucity of information relating to the 
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mechanism of mammary tissue L-glutamate transport we 
have designed experiments oexamine the transport of this 
anionic amino acid by lactating rat mammary tissue using 
both tissue explants and the perfused mammary gland. 
2. Materials and methods 
2.1. Animals 
Lactating Wistar rats, 10-15 days post partum, which 
were suckling 8-10 pups were used throughout this study. 
The animals were maintained on a 12 h light-12 h dark 
cycle and allowed free access to water and chow. 
2.2. Preparation of mammary tissue explants 
Mammary tissue explants were prepared according to 
the method described by Shennan [17]. Rats were lightly 
anaesthetized with ether and then killed by cervical dislo- 
cation. The abdominal mammary glands were immediately 
removed and placed in a buffer similar in composition to 
that required for the glutamate flux studies (see figure 
legends for details). The tissue was finely chopped to 
produce explants weighing between 0.5 and 2 mg. Care 
was taken to remove as much connective tissue as possi- 
ble. The tissue explants were rinsed repeatedly with buffer 
prior to the start of the experiment. 
2.3. Measurement of L-glutamate transport in mammary 
tissue explants 
2.3.1. L-Glutamate uptake 
L-Glutamate uptake, using L-[3H]glutamate as tracer 
was assayed at 37°C according to the method escribed in 
detail by Shennan [17]. Mammary tissue explants were 
incubated at 37°C in the appropriate buffer for at least 20 
min prior to the addition of L-[3H]glutamate. Following the 
addition of the radiotracer (at a final concentration of 
0.25-0.5 i~Ci/ml) the tissue was removed at pre-de- 
termined intervals and immediately washed with 4 ml of 
an ice-cold solution similar in composition to the incuba- 
tion medium except hat it did not contain any isotope. The 
tissue explants were lightly blotted and placed in pre- 
weighed tubes. After the tissue weight had been deter- 
mined, 4 ml of 10% trichloroacetic a id (TCA) was added. 
The tissue explants were left in the TCA f or at least 16 h. 
Afterwards the tubes were spun at 13 000 × g for 2 min. 1 
ml of the resulting supematants was removed and prepared 
for liquid scintillation counting. Aliquots of the incubation 
media were also counted. 
L-Glutamate uptake was corrected for the amount of 
L-[3H]glutamate associated with the extracellular space. 
Thus, the amount of [3H]sucrose trapped in the tissue 
extracellular space was estimated in parallel experiments. 
The sucrose space was calculated from the ratio of 
[3H]sucrose counts per g of tissue to [3H]sucrose counts 
per ml of incubation medium. 
The uptake of L-glutamate by tissue explants was calcu- 
lated according to Eq. (1): 
L -  [glutamate]c 
[L -- g lu tamate] t -  ([L -- glutamate]m. F )  
= (1)  
l - F  
where [L-glutamate] c is the cellular concentration of L- 
glutamate in nmol/g of cells, [L-glutamate] t is the total 
tissue concentration of L-glutamate in nmol/g of tissue 
wet weight, [L-glutamate]m is the concentration of L- 
glutamate in the incubation medium in nmol/ml and F is 
the sucrose space. 
2.3.2. L-Glutamate effiux 
L-Glutamate fflux, using L-[3H]glutamate as tracer, 
was assayed according to the method described by Shen- 
nan et al. [ 18]. Mammary tissue explants were loaded with 
radiolabelled L-glutamate by incubation at 20°C for 30-40 
min in a medium containing (mM) 0.001 glutamate, 135 
NaC1, 5 KCI, 2 CaC12, 1 MgSO4, 1 amino(oxy)acetic acid, 
10 glucose and 20 Tris-BES, pH 7.4 (+2-4  IxCi L- 
[3H]glutamate/ml). Following the loading period the tis- 
sue was transferred through a series of tubes containing 2.0 
ml of radioactive free solutions. At the end of the effiux 
assay the tissue was allowed to stand in 4.0 ml of a 10% 
TCA solution for at least 16 h. This tube was spun at 
13 000 X g for 2 min. I ml of the supernatant was re- 
moved and prepared for counting. The fractional efflux 
(min- 1 ) of L-glutamate from the tissue explants was calcu- 
lated as previously described [18]. 
2.4. Perfusion of mammary tissue 
The technique for the in situ, non-recirculating perfu- 
sion of inguinal/abdominal rat mammary tissue was es- 
sentially as described by Clegg and Calvert [19]. Anaesthe- 
sia was induced and maintained throughout by an i.p. 
injection of a sodium pentobarbitone solution (40 mg/kg 
of body wt.). The mammary gland was perfused via the 
superficial epigastric vessels. In control experiments the 
perfusate contained (raM) 118 NaC1, 4 KCI, 2 CaC12, 1 
MgSO 4, 1 NaH2PO 4, 10 glucose and 25 NaHCO 3. The 
buffer was gassed to pH 7.4 with 95% 02:5% CO 2. The 
perfusate was supplemented with 5% (w/v)  bovine serum 
albumin (BSA). When the Na+-dependence of L-glutamate 
transport was examined NaC1 and NaH2PO 4 were respec- 
tively replaced with an equimolar amount of N-methyl-D- 
glucamine (NMDG+)-CI and KH2PO 4. In addition, 
NaHCO 3 was replaced in both the control and Na+-free 
perfusates with 20 mM Tris-Hepes, pH 7.4. In these 
experiments he perfusates were gassed with 100% 02. 
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2.5. Measurement of L-glutamate transport by the perfused 
mammary gland 
The transport of L-glutamate, using L-[3H]glutamate as 
tracer, by the perfused mammary gland was measured 
using a rapid, paired tracer dilution technique first de- 
scribed by Yudilevich et al. [20]. A bolus containing 
L-[3H]glutamate and [14C]sucrose (the extracellular marker) 
was injected close arterially (60 ILl in < 2 s) and 20 
consecutive venous outflow samples were collected. The 
uptake (U) of L-glutamate for each collection period was 
calculated according to Eq. (2): 
U(%)  = 1 - ( R t /R i )  (2) 
where R t is the ratio of L-[3H]glutamate/[14C]sucrose in
the venous outflow at time t after the bolus injection and 
R i is the ratio of L-[3H]glutamate/[t4C]sucrose in the 
injectate. To standardise L-glutamate transport between 
each experiment we expressed the uptakes as a clearance 
(i.e., the volume of perfusate notionally cleared of L- 
[3H]glutamate). The clearances were calculated by multi- 
plying the uptakes (U) for each collection period by the 
perfusate flow rates (ml /min  per g of tissue wet wt.). 
In the experiments where the perfusates contained a 
known amount of unlabelled L-glutamate it was possible to 
calculate the unidirectional uptake (V t) from the maximum 
uptake (Uma x) according to Eq. (3): 
V t = - ln ( l  - Umax)  X F× C (3) 
where F is the perfusate flow and C is the perfusate 
concentration of unlabelled L-glutamate. 
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Fig. 1. The cation dependency of L-glutamate uptake by mammary tissue 
explants. Tissue was incubated in a medium containing (mM) 0.005 
L-glutamate, 135 XCI (where X = Na +, choline +, Li + or NMDG + ), 5 
KCI, 2 CaC12, 1 MgSO 4, 10 glucose and 20 Tris-Mops, pH 7.4. 
L-Glutamate uptake was assayed at 37°C after 2 min of incubation. The 
inset shows the time-course of L-glutamate uptake by mammary tissue 
explants incubated ina Na + buffer. Results hown are means + S.E.M. of 
3 experiments. 
uptake at 1 mM was linear for 2 min (results not shown). 
Fig. 1 illustates the effect of replacing extracellular Na + 
with either choline +, NMDG ÷ or Li ÷ on L-glutamate 
uptake. Glutamate uptake was almost abolished when the 
incubation medium did not contain Na ÷ (P  < 0.001). It 
appears, therefore, that the predominant route for L- 
glutamate uptake into mammary tissue explants is a Na +- 
dependent pathway. 
2.5.1. Statistics 
Where appropriate, values are expressed as mean _+ 
S.E.M. Differences were assessed by Student's paired or 
unpaired t-tests and were considered significant when 
P < 0.05. 
2.5.2. Chemicals 
L-[3H]Glutamate, [3H]sucrose and [14C]sucrose were 
obtained from Amersham International, Aylesbury, Bucks., 
UK. All other chemicals including the unlabelled amino 
acids were purchased from Sigma, Poole, Dorset, UK. 
3. Resu l ts  
3.1. L-Glutamate transport by mammary tissue explants 
3.1.1. Cation dependency of L-glutamate uptake by mam- 
mary tissue explants 
Preliminary experiments revealed that L-glutamate up- 
take (5 p.M) by mammary tissue explants was linear for at 
least 3 min (Fig. 1, inset). Therefore, in subsequent experi- 
ments L-glutamate influx was measured after 2 min of 
incubation. In one experiment we found that e-glutamate 
3.1.2. Cation dependency of L-glutamate ffiux from mam- 
mary tissue explants 
I f  the Na+-dependent component of L-glutamate uptake 
represented (Na+-glutamate) cotransport it was predicted 
that L-glutamate efflux from mammary tissue explants 
should also display a dependency on the transmembrane 
Na+-gradient. This prediction was based on the observa- 
tion of Bouvier et al. [4] that the Na+-dependent glutamate 
uptake carrier in glial cells can run backwards. Therefore, 
to test this prediction we studied the effect of reversing the 
Na+-gradient on the efflux of L-glutamate from tissue 
explants which were preloaded with radiolabelled L- 
glutamate. To do this we measured glutamate fflux into a 
buffer containing Na + as the principal cation followed by 
one where Na ÷ had been replaced by choline. The efflux 
rate constant of L-glutamate was increased from 0.0145 + 
0.0003 min -1 to 0.0299 _ 0.0017 min - I  (±  S.E.M., n = 6, 
P < 0.001) by reversing the Na + gradient in this manner. 
3.1.3. Kinetic parameters of L-glutamate uptake by mam- 
mary tissue explants 
The kinetic parameters (i.e., K m and Vma x) of L-gluta- 
mate uptake by mammary tissue explants were examined. 
In this set of experiments the L-glutamate concentration i  
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Fig. 2. The L-glutamate concentration dependence of L-glutamate uptake 
by mammary tissue xplants in the presence (©) and absence (A) of 
Na +. Tissue was incubated in a buffer containing (mM) 0.005-0.3 
L-glutamate, 135 XCI (where X = Na + or choline +), 5 KC1, 2 CaC12, 1 
MgSO 4, 10 glucose and 20 Tris-Mops, pH 7.4. L-Glutamate uptake was 
assayed at 37°C after 2 min of incubation. The points shown are the 
means +S.E.M. of 5 experiments. 
the incubation medium was varied over the range 5-300 
IxM in the presence and absence of Na + (choline replace- 
ment). It is clear from Fig. 2 that L-glutamate uptake, in 
the presence of Na +, was saturable with respect to the 
extracellular L-glutamate concentration. In contrast, L- 
glutamate uptake in the absence of extracellular Na + was 
substantially reduced and was not saturable over the con- 
centration range tested. A Hanes-Woolf plot of the Na ÷- 
dependent moiety of uptake suggested that there was a 
single system for L-glutamate uptake. The calculated K m 
and Vma x was respectively 112.5 + 19.7 IxM and 71.3 ___ 
10.4 nmol /min  per g of cells ( _  S.E.M., n = 5). 
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Fig. 3. The effect of amino acids on L-glutamate uptake by mammary 
tissue xplants. Tissue was incubated in a buffer containing (mM) 0.005 
L-glutamate, 135 NaC1, 5 KCI, 2 CaCI 2, 1 MgSO 4, 10 glucose and 20 
Tris-Mops, pH 7.4. When required, the test amino acids were present at 
5mM. L-Glutamate uptake was assayed at37°C after 2 min of incubation. 
The numbers in parentheses r present the number of experiments per- 
formed with each amino acid. Results hown are means +S.E.M. 
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Fig. 4. The concentration dependence of inhibition by anionic amino 
acids of L-glutamate uptake by mammary tissue explants. The points 
denoted (11), (O), and (A), respectively, represent the addition of 
varying concentrations f L-aspartate, D-aspartate, and D-glutamate. The 
incubation conditions were the same as those described in Fig 3. The 
points hown are the means +S.E.M of 3 experiments. 
3.1.4. Amino acid specificity of  the L-glutamate carrier in 
mammary tissue explants 
We next studied the substrate specificity of the Na+-de - 
pendent carrier by examining the effect of adding a variety 
of unlabelled amino acids (at 5 mM) to the incubation 
medium on glutamate uptake (at 5 IxM). It is evident from 
Fig. 3 that L-glutamate uptake was markedly inhibited by 
D- and L-aspartate and less so by D-glutamate. Fig. 3 also 
shows that L-glutamate uptake was relatively insensitive to 
neutral amino acids and to L-lysine. These results sug- 
gested to us that the L-glutamate carrier was selective for 
anionic amino acids. The concentration dependence of 
inhibition by the anionic amino acids was then examined. 
The IC5o of inhibition by D- and L-aspartate, calculated 
from the data shown in Fig. 4 was 15.9-t-8.8 txM and 
40.6 _+ 0.7 ixM, respectively. The IC50 of inhibition by 
D-glutamate was greater than 1 raM. The inhibition of 
L-glutamate uptake by o-aspartate was found to be of a 
competitive nature, thus, the presence of 20 IxM D-aspar- 
tate in the incubation medium increased the K m of L- 
glutamate uptake from 112 -t- 19.7 p.M to 408.6 -t- 103.9 
txM (_+ S.E.M., n - 3, P < 0.05). In contrast the presence 
of aspartate did not significantly change the Vma x (71.3 _+ 
10.4 VS. 85.8 _+ 18.9 nmol /min  per g of cells, respectively, 
in the absence and presence of D-aspartate). 
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Fig. 5. The clearance profile of L-glutamate by the perfused mammary 
gland in the presence (©) and absence (• )  of Na ÷ in the perfusate. The 
gland was perfused with a buffer containing (mM) 118 XCI (where 
X=Na ÷ or NMDG +), 4 KCI, 2 CaC12, 1 MgSO 4, 1 KH2PO4, 10 
glucose and 20 Tris-Hepes, pH 7.4. The perfusate also contained BSA 
(5%, w/v)  and was gassed with 100% 02. The points shown are the 
means + S.E.M. of 5 experiments. 
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Fig. 6. The effect of unlabelled D-aspartate (zx), L-aspartate (• ) ,  D- 
glutamate (v )  and L-leucine ( I )  on the clearance of L-glutamate by the 
perfused mammary gland. Each amino acid was added to the injectate at a 
concentration of 50 mM. The clearance in the absence of amino acids 
(i.e., the control) is shown by the open circles. The perfusate contained 
(mM) 118 NaC1, 4 KC1, 2 CaCI 2, 1 MgSO 4, 1 NaH2PO4, 10 glucose and 
25 NaHCO 3. The perfusate also contained 5% BSA (w/v) and was 
gassed to pH 7.4 with 95% 02 / 5% CO 2. The points shown are the 
means of 3 experiments. For the sake of clarity error bars have been 
omitted. 
3.2. L-Glutamate transport by the perfused mammary 
preparation 
3.2.1. Na +-dependence of transport by the perfused mam- 
mary preparation 
Fig. 5 shows the clearance profile of L-[3H]glutamate 
by the perfused gland in the presence and absence of Na +. 
In this set of experiments he peffusate and injectate did 
not contain any unlabelled L-glutamate: this was to maxi- 
mize the extraction of L-[3H]glutamate by the mammary 
gland. In the presence of extacellular Na ÷, the time course 
of L-[3H]glutamate clearance consisted of a rising phase 
followed by a rapid fall off. The rising phase is governed 
by the unidirectional uptake of radiolabelled L-glutamate. 
The presence of a rising phase suggests that there may be a 
significant portion of the perfusate which bypasses capil- 
laries supplying the secretory acini (i.e. an A-V shunt). 
The fall off is probably due to tracer efflux from the tissue 
back into the perfusate. It is evident from Fig. 5 that the 
clearance of tracer L-glutamate is Na÷-dependent, thus, 
replacing Na ÷ with NMDG ÷ resulted in a marked fall in 
the clearance. 
3.2.2. Substrate specificity of L-glutamate transport by the 
perfused mammary preparation 
To characterise the transport of L-[3H]glutamate by the 
perfused gland with respect to substrate specificity we 
studied the effect of a range of amino acids on the 
clearance of L-[aH]glutamate. On the basis of the explant 
studies we examined the effect of D-glutamate, D- and 
L-aspartate and L-leucine. In this series of experiments he 
'test' amino acids were co-injected with the radiotracers. 
Thus, the bolus contained the amino acids at a concentra- 
tion of 50 mM. Although this appears to be a high 
concentration f the putative substrates it must be borne in 
mind that the concentration at the site of transport would 
have been lower owing to the diluting effect of the per- 
fusate. It is clear from Fig. 6 that the clearance of L- 
[3 H]glutamate was reduced by aspartate (both the D and L 
isomers) but not by D-glutamate or L-leucine. 
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Fig. 7. The concentration dependence of L-glutamate clearance by the 
perfuscd mammary gland. The perfusate contained varying concentrations 
of unlabelled L-glutamate; ( I )  l0 v,M, (A)  50 I-~M, (V)  100 ~M, (~) 
300 I.LM. The pcrfusate also contained (mM) 118 NaCI, 4 KC1, 2 CaC12 ,
1 MgSO 4, 1 KH2PO 4, 10 glucose and 25 NaHCO 3. The perfusate was 
supplemented with 5% BSA (w/v) and was gassed to pH 7.4 with 95% 
02/5% CO 2. The points shown are the means of 3 experiments. For the 
sake of clarity error bars have been omitted. The inset shows the 
unidirectional influx (V t) plotted as a function of the L-glutamate concen- 
tration. 
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3.2.3. Kinetics of  L-glutamate transport by the perfused 
mammary preparation 
The kinetics parameters (i.e., the K m and Vma x) of 
L-glutamate transport by the perfused lactating mammary 
gland were examined. Unlabelled L-glutamate, at known 
concentrations, was added to both the perfusate and injec- 
tate and the clearance of L-[3H]glutamate was measured 
for each concentration (Fig. 7). Apparently, the clearance 
of radiolabelled glutamate decreased as the concentration 
of unlabelled L-glutamate increased: this is consistent with 
the presence of cartier mediated transport. The unidirec- 
tional uptake (V t) of glutamate, using the Urea x values, was 
calculated according to equation 3. V t was plotted as a 
function of the perfusate L-glutamate concentration (Fig. 
7). It is clear that L-glutamate uptake by the perfused 
gland, like that of tissue explants, displays aturation kinet- 
ics. Plotting the data shown in Fig. 7 as a Hanes-Woolf 
plot revealed that the K m and Vma x of transport were, 
respectively, 18.1 + 4.9 I~M and 40.3 +__ 3.7 nmol/min per 
g of tissue (+ S.E.M., n = 3). 
4. Discussion 
The experiments described in this report were con- 
ducted to investigate the mechanism of L-glutamate trans- 
port by lactating rat mammary tissue. This was done 
because there is no information about L-glutamate trans- 
port in this tissue despite the importance of this anionic 
amino acid to mammary gland metabolism. We employed 
two experimental systems to measure L-glutamate transport 
by rat mammary tissue, namely tissue explants and the 
perfused mammary gland. We used the data generated 
from the explant experiments o design experiments using 
the technically demanding perfused mammary preparation 
thus maximising our efforts. 
It is apparent that the major pathway for L-glutamate 
uptake by mammary tissue is a Na+-dependent system. 
This taken together with the finding that the efflux of 
L-glutamate from mammary tissue explants can be in- 
creased by reversing the transmembrane Na+-gradient sug- 
gests that the mechanism of transport is a (Na--glutamate) 
cotransporter. This cotransporter is a saturable system 
which appears to prefer anionic amino acids as substrates. 
The mammary glutamate carrier was inhibited by D- and 
L-aspartate with similar affinity but was more sensitive to 
L-glutamate than D-glutamate. Indeed, the finding that the 
ICso of inhibition of L-glutamate transport by the isomers 
of aspartate was lower than the K m of glutamate transport 
suggests that the carrier may have a higher affinity for 
aspartate. This pattern of selectivity leads us to suggest 
that the Na+-dependent L-glutamate cartier in mammary 
tissue may be system XAC which has been described 
elsewhere. System XAC couples the transport of Na + and 
L-glutamate to the efflux of K + and OH-. The experimen- 
tal systems we used did not readily allow us to examine 
the role of K + in the transport of L-glutamate by the 
mammary gland. 
L-Glutamate uptake by the perfused lactating mammary 
gland had similar characteristics to that of L-glutamate 
transport in explants. Thus, L-glutamate xtraction by the 
perfused gland was via a high affinity, Na+-dependent 
system which preferred anionic amino acids as substrates. 
An analysis of the kinetic data suggested that there is only 
one system for L-glutamate transport in mammary tissue 
explants. Therefore, it would appear that the system identi- 
fied in explants is situated in the blood-facing aspect of the 
mammary epithelium. However, we cannot rule out the 
presence of a Na+-dependent system in the apical aspect of 
the epithelium which has kinetic characteristics identical to 
that of the carrier in the basolateral membranes. A Na÷-de - 
pendent L-glutamate carrier situated in the basolateral 
membrane of mammary secretory cells would be ideally 
situated to generate the large intra- to extracellular L- 
glutamate concentration gradient across the plasma mem- 
branes of mammary secretory cells [18]. Interestingly, 
despite this large gradient it seems that mammary tissue, 
unlike other tissues [21,22], does not use L-glutamate to 
volume regulate following swelling. Thus, Shennan et al. 
[18] found that the efflux of L-glutamate, unlike that of 
taurine and glycine, was unaffected by a hyposmotic chal- 
lenge and hence cell-swelling. 
Although the characteristics of L-glutamate transport by 
the perfused mammary preparation were similar to that 
found with explants there was an interesting difference in 
the kinetic parameters. The K m for L-glutamate uptake by 
explants and the perfused gland was respectively 112.5 and 
18.1 ~M. We believe that the difference reflects the 
presence of larger unstirred water layers in the tissue 
explants compared to that found in the perfused gland. 
Such layers would mean that the concentration f substrate 
at the site of transport could be significantly less than that 
of the bulk phase and would lead to an overestimation f 
the K m in tissue explants [23]. However, the Krn of 
L-glutamate transport obtained by both preparations falls 
within the range previously reported for system XAG. 
The lactating rat mammary gland is capable of generat- 
ing a large arterio-venous glutamine concentration gradient 
[16]. Indeed, in the rat, the mammary arterio-venous glu- 
tamine gradient is larger than that for glutamate. Glu- 
tamine is an important source of glutamate in a number of 
cell types. However, the present finding that mammary 
cells express a glutamate carrier suggests that rat mam- 
mary cells do not have to completely rely on glutamine as 
a source of intracellular glutamate. 
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